Skip to main content
hello world

Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.

Cancer Research Sees Major Boost as New Breakthroughs Emerge from Key Oncology Players

Newswire.ca - Thu Sep 19, 11:08AM CDT

USA News Group Commentary
Issued on behalf of Oncolytics Biotech Inc.

VANCOUVER, BC, Sept. 19, 2024 /CNW/ -- USA News Group – In the oncology world, there's been plenty to celebrate recently, with cancer deaths falling by 33% in the last 30 years. However, there's still a lot of work to do in the war on cancer, with the 2024 World Cancer Congress in Geneva highlighting several issues, such as artificial intelligence (AI), conflict zones and crisis care taking center stage at the gathering. Plenty of support for research continues to roll in, with philanthropists recently giving a historic $150 million for pancreatic cancer research to City of Hope, while Stanfordexperts are calling for more massive federal funding increases to cancer research. At the research level, several players are making significant progress in oncology, with recent developments coming from Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), Novartis AG (NYSE: NVS), Lantheus Holdings, Inc. (NASDAQ: LNTH), Sutro Biopharma, Inc. (NASDAQ: STRO), and Zymeworks Inc. (NASDAQ: ZYME).

Read more at newswire.ca